5PSQ-092 Analysis of off-label uses of inhalers in hospitalised patients

BACKGROUND: The high prevalence of respiratory diseases leads to high consumption of inhaled bronchodilators (IBs) not always appropriately indicated. It is important for patients and for the healthcare systems that a proper indication and use not only achieves greater efficacy and adherence to the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Hosp Pharm
Päätekijät: Villamañán, E, Freire, M, Sobrino, C, Jiménez, I, Lara, C, Ruano, M, Pérez, E, Jiménez, C, Rossignoli, A, Herrero, A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2018
Aiheet:
Section 5: Patient safety and quality assurance
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535335/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.445
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia